← Back
$ANRO All transactions

Alto Neuroscience, Inc.

A

$ Value

Shares

76,000

Price

Filed

Jul 8

Insider

Name

Savitz Adam

Title

CHIEF MEDICAL OFFICER

CIK

0002008707

Roles

Officer

Transaction Details

Transaction Date

2025-07-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

76,000

Footnotes

The shares subject to the option are fully vested and exercisable. | The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on July 3, 2025 (the "Repricing Date"). The Option Repricing applies to options with exercise prices greater than $2.35 per share held by continuing employees of the Issuer as of the Repricing Date. | Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.35 per share, the closing price of the Issuer's common stock on the Repricing Date. However, if an employee exercises a repriced option before the end of a retention period of one year (subject to earlier termination in certain circumstances), such employee will be required to pay the original exercise price per share of such repriced option. There is no change to the vesting schedules, expiration dates of, or number of shares underlying the repriced options. | 25% of the shares underlying the option vested on January 1, 2024, and one forty-eighth (1/48th) of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. | 25% of the shares underlying the option vested on December 20, 2024, and one forty-eighth (1/48th) of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. | 25% of the shares underlying the option vested on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. | 25% of the shares underlying the option shall vest on February 5, 2026, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Filing Info

Accession No.

0001999480-25-000064

Form Type

4

Issuer CIK

0001999480

Savitz Adam's History

Date Ticker Type Value
2026-02-11 ANRO A $0
2025-07-03 ANRO A
2025-07-03 ANRO D
2025-07-03 ANRO A
2025-07-03 ANRO D
2025-07-03 ANRO A
2025-07-03 ANRO D
2025-07-03 ANRO A
2025-07-03 ANRO D
2025-07-03 ANRO A

Other Insiders at ANRO (90d)

Insider Bought Sold Last
Hanley Jr. Michael Conick
CHIEF OPERATING OFFICER
2026-02-11
Etkin Amit
PRESIDENT AND CEO
2026-03-01
Savitz Adam
CHIEF MEDICAL OFFICER
2026-02-11
Smith Nicholas Conrad
CHIEF FINANCIAL OFFICER & CBO
2026-03-01